Pelzer, Esther A.
Pauls, K. Amande M.
Braun, Nina
Tittgemeyer, Marc
Timmermann, Lars
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (KFO-219, KFO-219)
Universität zu Köln (Köln Fortune Grant 185/2016)
Article History
Received: 28 September 2019
Accepted: 18 April 2020
First Online: 3 May 2020
Compliance with ethical standards
:
: Esther Pelzer has no disclosures. Amande Pauls has no disclosures. Nina Braun has no disclosures. Marc Tittgemeyer has no disclosures. Lars Timmermann reports grants, personal fees and non-financial support from Medtronic, grants, personal fees and non-financial support from Boston Scientific, personal fees and non-financial support from SAPIENS, grants, personal fees and non-financial support from St. Jude Medical, during the conduct of the study; grants and personal fees from Bayer Healthcare, grants, personal fees and non-financial support from UCB Schwarz Pharma, grants, personal fees and non-financial support from Archimedes Pharma, grants, personal fees and non-financial support from TEVA Pharma, grants, personal fees and non-financial support from Lundbeck Pharma, personal fees from Medas Pharma, grants, personal fees and non-financial support from Desitin Pharma, personal fees and non-financial support from GlaxoSmithKline, personal fees and non-financial support from Orion Pharma, grants, personal fees and non-financial support from Abbvie, personal fees from TAD Pharma, grants from zur Rose Pharma, outside the submitted work.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of medical faculty of the University Cologne; study number: 12-286 and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.